Autoantibodies to nervous system-specific proteins are elevated in sera of flight crew members: Biomarkers for nervous system injury

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 76, Issue 6, 2013, Pages 363-380

  Abou Donia, Mohamed B ^a   Abou Donia, Martha M ^a   Elmasry, Eman M ^a   Monro, Jean A ^b   Mulder, Michel F A ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Breakspear Medical Group   (United Kingdom)

^c Aviation Medical Consultation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROFILAMENT PROTEIN; ORGANOPHOSPHATE; PROTEIN S100B; TAU PROTEIN; TUBULIN;

ADULT; AIRPLANE PILOT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DEPRESSION; DESCRIPTIVE RESEARCH; DIARRHEA; DISEASE MARKER; DYSLEXIA; FATIGUE; FEAR; GLIOSIS; HEADACHE; HUMAN; MALE; MEMORY DISORDER; MUSCLE WEAKNESS; NAUSEA; NERVE INJURY; NERVOUS SYSTEM INJURY; NEUROFILAMENT; POLLAKISURIA; PRIORITY JOURNAL; SELF REPORT; SLURRED SPEECH; TACHYCARDIA; WESTERN BLOTTING;

AEROSPACE MEDICINE; AIR POLLUTANTS, OCCUPATIONAL; AUTOANTIBODIES; AVIATION; BIOLOGICAL MARKERS; CONFINED SPACES; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOGLOBULIN G; INHALATION EXPOSURE; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MYELIN BASIC PROTEIN; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; NEUROTOXICITY SYNDROMES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; S100 PROTEINS; TAU PROTEINS; TUBULIN;

EID: 84876145549     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2013.765369     Document Type: Article

References (93)

1. Abdel-Rahman, A., Shetty, A. K., and Abou-Donia, M. B. 2002. Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: Dose response relationship. Neuroscience 113: 721-741. (Pubitemid 34874696)
2. Abou-Donia, M. B. 1981. Organophosphorus ester-induced delayed neurotoxicity. Annu. Rev. Pharmacol. Toxicol. 21: 511-548.
3. Abou-Donia, M. B. 1993. The cytoskeleton as a target for organophosphorus ester-induced delayed neurotoxicity (OPIDN). Chem. Biol. Interact. 87: 383-393. (Pubitemid 23205403)
4. Abou-Donia, M. B. 1995. Involvement of cytoskeletal proteins in the mechanisms of organophosphorus ester-induced delayed neurotoxicity. Clin. Exp. Pharmacol. Physiol. 22: 358-359.
5. Abou-Donia, M. B. 2003. Organophosphorus ester-induced chronic neurotoxicity. Arch. Environ. Health 58: 484-497. (Pubitemid 38828868)
6. Abou-Donia, M. B., and Garretson, L. K. 2000. Detection of neurofilament autoantibodies in human serum following chemically induced neurologic disorder: A case report. Environ. Epidemiol. Toxicol. 2: 1-5.
7. Abou-Donia, M. B., and Lapadula, D. M. 1990. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: Type I and Type II. Annu. Rev. Pharmacol. Toxicol. 30: 404-440.
8. Abou-Donia, M. B., Viana, M., E., Gupta, R., P., and Knoth-Anderson J. 1993. Enhanced calmodulin binding concurrent with increased kinase-dependent phosphorylation of cytoskeletal proteins following a single subcutaneous injection of diisopropyl phosphorofluoridate (DFP) in hens. Neuochem. Int. 22: 165-173.
9. Abou-Donia, M .B., Wilmarth, K. R., Jensen, K. F., Oehme, F. W., and Kurt, T. L. 1996. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin: Implications of Gulf War chemical exposures. J. Toxicol. Environ. Health 48: 35-56.
10. Ahlsen, G., Rosengren, L., Belfrage, M. Palm, A. Haglid, K., Hamberger, A., and Gillberg, C. 1993. Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol. Psychiatry 33: 734-743. (Pubitemid 23205331)
11. American Conference of Governmental Industrial Hygienists. 1986. Documentation of the threshold limit values and biological exposure indices. Cincinnati, OH: ACGIH.
12. Arolt, V., Peters, M., Erfurth, A., Weismann, M., Missler, U., Rudolf, S., Kirchner, H., and Rothermundt, M. 2003. S100B and response to treatment in major depression: A pilot study. Eur. Neuropsychopharmacol. 13: 235-239. (Pubitemid 36904049)
13. Aurell, A., Rosengren, L. E., Karlsson, B., Olsson, J. E., and Zbornikova, V., and Haglid, K. G. 1991. Determination of S-100 and glial fibrillary acidic protein concentration in cerebrospinal fluid after brain infarction. Stroke 22: 1254-1258.
14. Bloch, H., and Hottinger, A. 1943. Über die Spezifitäder Cholinesterase-Hummung durch Tri-o-kresyl-phosphat. Z. Vitaminforsch. 13: 142-155.
15. Brady, S. T. 1993. Motor neurons and neurofilament in sickness and health. Cell 73: 1-3. (Pubitemid 23115442)
16. Burns, R. G., Islam, K., and Chapman R. 1984. The multiple phosphorylation of the microtubule-associated protein MAP-2 controls the MAP2: Tubulin interaction. Eur. J. Biochem. 141: 609-615. (Pubitemid 14082359)
17. Carletti, E., Schopfer L. M., Colletier, J.-P., Froment, M.-T., Nachon, F., Weik, M., Lockridge, O., and Masson, P. 2011. Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: Mechanistic studies employing kinetics, mass spectrometry, an X-ray structure analysis. Chem. Res. Toxicol. 24, 797-808.
18. Cox, L., and Michaelis, S. 2002. A survey of health symptoms in BAe 146 aircrew. J. Occup. Health Safety Aust. N. Z. 18: 305-312.
19. Craig, P. H., and Barth, M. L. 1999. Evaluation of the hazards of industrial exposure to tricresyl phosphate. J. Toxicol. Environ. Health B 2: 281-300.
20. Damadaran, T. V., Attia, M. K. M., and Abou-Donia, M. B. 2011. Early differential cell death and survival mechanisms initiate and contribute to the development of OPIDN: A study of molecular, cellular, and anatomical parameters. Toxicol. Appl. Pharmacol. 256: 348-359
21. Damodaran, T. V., Gupta, R. P., Attia, M. K., and Abou-Donia, M. B. 2009. DFP initiated early alterations of PKA/p-CREB pathway and differential persistence of β-tubulin subtypes in the CNS of hens contributes to OPIDN. Toxicol. Appl. Pharmacol. 240: 132-142.
22. De Lorenzo, R. J., Albert, J. P., and DeLucia, P. R. 1982. Ca2 Kinase dependent filamentous polymerization of tubulin. Soc. Neurosci. 12th Annual Meeting Abstract, Minneapolis, MN, 281.
23. De Nola G, Kibby J., and Mazurek, W. 2008. Determination of ortho-cresyl phosphate isomers of tricresyl phosphate used in aircraft turbine engine oils by gas chromatography and mass spectrometry. J. Chromatogr. A 1200: 211-216.
24. Dotevall, L., Hagberg, L., Karlsson, J. E., and Rosengren, L. E. 1999. Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis. Eur. J. Neurol. 6: 169-178. (Pubitemid 29141898)
25. Earl, C. J., and Thompson, R. H. S. 1952. The inhibitory action of tri-ortho-cresyl phosphate and cholinesterases. Br. J. Pharmacol. 7:261-269.
26. El-Fawal, H. A., Waterman S. J., De Foe, A., and Shamy, M. Y. 1999. Neuroimmunotoxicology: Humoral assessment of neurotoxicity and autoimmune mechanisms. Environ. Health Perspect. 107(suppl. 5): 767-775. (Pubitemid 29527782)
27. Eng, L. F., and Ghirnikar, R. S. 1994. GFAP and astrogliosis. Brain Pathol .4: 229-237. (Pubitemid 24261929)
28. Freudenthal, R. I., Rausch, L., Gerhart, J. M., Barth, M. L., Mackerer, C. R., and Bisinger, E. C. 1993. Subchronic neurotoxicity of oil formulations containing either tricresyl phosphate or tri-orthocresyl phosphate. J. Am. College Toxicol. 12: 409-501
29. Fuchs, E., and Cleveland, D. W. 1988. A structural scaffolding of intermediate filaments in health and disease. Science 279:514-519.
30. Grabe, H. J., Ahrens, N., Rose, H. J., Kessler, C., and Freyberger, H. J. 2001. Neurotrophic factor S100beta in major depression. Neuropsychobiology 44: 88-90. (Pubitemid 32722306)
31. Griffin, W. S. T., Stanley, L. C., Ling, C., White, C., Macleod, V., Perrot, L. J., White, C. L. III, and Aroaz, C. 1989. Brain interlukin 1 and S-100 immunoreactivity are elevated in Down's syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 86: 7611-7615. (Pubitemid 19254506)
32. Gupta, R. P., Abdel-Rahman, A., Wilmarth, K. W., and Abou-Donia, M. B. 1997. Alteration in neurofilament axonal transport in the sciatic nerve of the diisopropyl phosphorofluoridate (DFP)-treated hens. Biochem. Pharmacol. 53:1799-1806. (Pubitemid 27356052)
33. Gupta, R. P., Abdel-Rahman, A., Jensen, K. F., and Abou-Donia, M. B. 2000a. Altered expression of neurofilament subunits in diisopropyl phosphorofluoridate-treated hen spinal cord and their presence in axonal aggregates. Brain Res. 878: 32-47.
34. Gupta, R. P., and Abou-Donia, M. B. 1994. In vivo and in vitro effects of diisopropyl phosphorofluoridate (DFP) on the rate of hen brain tubulin polymerization. Neurochem. Res. 19: 435-444. (Pubitemid 24286611)
35. Gupta, R. P., and Abou-Donia, M. B. 1995a. Diisopropyl phosphorofluoridate (DFP) treatment alters calcium-activated proteinase activity and cytoskeletal proteins in the hen sciatic nerve. Brain Res. 677: 162-166.
36. Gupta, R. P., and Abou-Donia, M. B. 1995b. Neurofilaments phosphorylation and [125I] calmodulin binding by Ca2 protein kinase in the brain subcellular fractions of diisopropyl phosphorofluoridate (DFP)-treated hens. Neurochem. Res. 20: 1095-1110.
37. Gupta, R. P., and Abou-Donia, M. B. 1999. Tau phosphorylation by diisopropyl phosphorofluoridate (DFP)-treated hen brain supernatant inhibits its binding with microtubules: Role of Ca2dependent protein kinase II in tau phosphorylation. Arch. Biochem. Biophys. 365: 268-278. (Pubitemid 29391636)
38. Gupta, R. P., and Abou-Donia, M. B. 2001. Enhanced activity and level of protein kinase A in the spinal cord supernatant of diisopropyl phosphorofluoridate (DFP)-treated hen. Distribution of protein kinases and phosphatases in spinal cord subcellular fractions. Mol. Cell. Biochem. 220: 15-23. (Pubitemid 32519933)
39. Gupta, R. P., Bing, G., Hong, J.-S., and Abou-Donia, M. B. 1998. cDNA cloning and sequencing of Ca2dependent protein kinase IIα subunit and its expression in diisopropyl phosphorofluoridate (DFP)-treated hen central nervous system. Mol. Cell. Biochem. 181: 29-39. (Pubitemid 28127775)
40. Gupta, R. P., Damodaran, T. V., and Abou-Donia, M. B. 2000b. c-fos mRNA induction in the central and peripheral nervous system of diisopropyl phosphorofluoridate (DFP)-treated hens. Neurochem. Res. 25: 327-334. (Pubitemid 30161477)
41. Hisanaga, S.-L., and Hirokawa, N. 1990. Dephosphorylation-Induced interactions of neurofilaments with microtubules. J. Biol. Chem. 265: 21852-21858. (Pubitemid 120014234)
42. Hoshi, M., Akiyama, T., Shinohara, Y., Miyata, Y., Ogawara, H., Nishida, E., and Sakai, H. 1988. Protein kinase C catalyzed phosphorylation of the microtubule-binding domain of microtubule associated protein 2 inhibits its ability to induce tubulin polymerization. Eur. J. Biochem. 174: 225-230.
43. Ingram, C. R, Phegan, K. J., and Blumenthal, H. T. 1974. Significance of an aging-linked neuron-binding gamma globulin fraction of human serum. J. Gerontol. 29: 20-27.
44. Institute of Environment & Health. 2011. Aircraft cabin air sampling study: Parts 1 and 2 of the final report. Cranfield, England: Institute of Environment & Health, Cranfield University.
45. Jauch, E. C., Lindsell, C., Broderick, J., Fagan, S. C., Tilley, B. C., and Levine, S. R. 2006. Association of serial biochemical markers with acute ischemic stroke. Stroke 37: 2508-2513.
46. Jensen, K. F., Lapadula, D. M., Anderson, J. K., Haykal-Coates, N., and Abou-Donia, M. B. 1992. Anomalous phosphorylated neurofilament aggregations in central and peripheral axons of hens treated with triortho-cresyl phosphate (TOCP). J. Neurosci. Res. 33: 455-460.
47. Jiang, W., Duysen, E. G., Hansen, H., Shlyakhtenko, L., Schopfer, L., and Lockridge, O. 2010. Mice treated with chlorpyrifos or chlorpyrifos oxon have organophosphorylated tubulin in brain and disrupted microtubule structures, suggesting a role for tubulin in neurotoxicity associated with exposure to organophosphate agent. Toxicol. Sci. 115: 183-193.
48. Johnson, M. K. 1969. A phosphorylation site in brain and delayed neurotoxic effect of some organophosphorus compounds. Biochem. J. 111: 487-495.
49. Kapural, M., Krizanac-Bengez, L., and Barnet, G. 2002. Serum S100beta as a possible marker of blood-brain-barrier disruption. Brain Res. 940: 102-104. (Pubitemid 34521759)
50. Kitzes, G. 1956. Cabin air contamination problems in jet aircraft. Aviation medicine, J. Aero Med. Assoc. 2: 53-58.
51. Kovesdi, E., Lucki, J., Bukovics, P.,Orsolya, F., Pal, J., Czeiter, E., Szellar, D., Doczi, T., Komoly, S., and Buki, A. 2010. Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir. 152: 1-17.
52. Laferrière, N. B., McRae T. H., and Brown D. L. 1997. Tubulin synthesis and assembly in differentiating neurons. Biochem. Cell Biol. 75: 103-117. (Pubitemid 127733134)
53. Lapadula, E. S., Lapadula, D. M., and Abou-Donia, M. B. 1991. Persistent alterations of calmodulin kinase II activity in chicken after an oral dose of tri-o-cresyl phosphate. Biochem. Pharmacol. 42: 171-180.
54. Lapadula, E. S., Lapadula, D. M., and Abou-Donia, M. B. 1992. Biochemical changes in sciatic nerve of hens treated with tri-ocresyl phosphate: Increased phosphorylation of cytoskeletal proteins. Neurochem. Int. 20: 247-255.
55. Lee, V. M.-Y., Otvos, L., Jr., Carden, J. J., Hollosi, M., Duetzschold, B., and Lazzarini R. A. 1988. Identification of the major multiphosphorylation sites in mammalian neuron filaments. Proc Natl. Acad. Sci. USA 85: 1998-2002. (Pubitemid 24315812)
56. Liliang, P.-C., Liang, C.-L., Weng, H.-C., Lu, K., Wang, K. W., Chen, H.-J., and Chang, J.-H. 2010. Proteins in serum predicts outcome after severe traumatic brain injury. J. Surg. Res. 160: 302-307.
57. Lipscomb, J., Walsh, M., Caldwell, D., and Narayanan, L. 1995. Inhalation toxicity of vapor phase lubricants. Report no. AL/OE-TR-1997-0090. Wright-Patterson Air Force Base, OH: U.S. Air Force Armstrong Laboratory, Occupational and Environmental Health Directorate, Toxicology Division.
58. Liyasova, M., Li, B., Schopfer, L. M., Nachon, F., Masson, P., Furlong, C. E., and Lockridge, O. 2011. Exposure to tri-o-cresyl phosphate detected in jet airplane passengers. Toxicol. Appl. Pharmacol. 256: 337-347.
59. LoPachin, R. M., Lapadula, D. M., and Abou-Donia, M. B. 1988. Organophosphate intoxication alters distribution of elements in chicken peripheral axons. Society for Neuroscience 18th Annual Meeting, Toronto, Canada, Abstracts Proceedings, Vol. 4, 775.
60. Machado-Vieira, R., Lara, D. R., Portela, L. V., Goncalves, C. A., Soares, J. C., Kapczinski, F., and Souza, D. O. 2002. Elevated serum S100 protein in drug-free bipolar patients during first manic episode: A pilot study. Eur.Neuropsychopharmacol. 12: 269-272. (Pubitemid 34462220)
61. Mackerer, C. R., Barth, M. L., Krueger, A. J., Chawla, B., and Roy, T. A. 1999. Comparison of neurotoxic effect and potential risks from oral administration or ingestion of tricresyl phosphate and jet engine oil containing tricresyl phosphate. J. Toxicol. Environ. Health A 57: 293-382.
62. Marisillach, J., Richtter, R. S., Kim, J. H., Stevens, R. C., MacCoss, M. J., Tomazela, D., Suzuki, S. M., Schopfer, L. M., Lockridge, O., and Furlong, C. E. 2011. Biomarkers of organophosphates (OP) exposures in humans. Neurotoxicology 32: 656-660.
63. Mattie, D. R., Hoeflich, T. J., Jones, C. E., Horton, M. L., and Whitmire, R. E. 1993. The comparative toxicity of operational Air Force hydraulic fluids. Toxicol. Ind. Health 9: 995-1016. (Pubitemid 24080380)
64. McConnell, R., Delgado-Tellez, E., Cuadra, R., Torres, E., Keifer, M., Almendarez, J., Miranda, J., El-Fawal, H. A., Wolff, M., Simpson, D., and Lundberg, I. 1999 Organophosphate neuropathy due to methamidophos: Biochemical and neurophysiological markers. Arch. Toxicol. 73: 296-300. (Pubitemid 29409033)
65. Montgomery, M. R.,Wier, G. T., Zieve, F. J., and Anders,M.W. 1977. Human intoxication following inhalation exposure to synthetic jet lubricating oil. Clin. Toxicol. 11: 423-426.
66. Murawski, J. T. L. and Supplee, D. S. 2008. An attempt to characterize the frequency, health impact, and operational costs of oil in the flight deck and cabin supply air on US commercial aircraft. J. Am. Soc. Test Mater., paper JAI101640. doi:10.1520/JAI101640
67. Patton, S. E., O'Callaghan, J. P., Miller, D. B., and Abou-Donia, M. B. 1983. Effect of oral administration of tri-o-cresyl phosphate on in vitro phosphorylation of membrane and cytosolic proteins from chicken brain. J. Neurochem. 41: 897-901.
68. Patton, S. E., Lapadula, D. M., O'Callaghan, J. P., Miller, D. B., and Abou-Donia, M. B. 1985. Changes in vitro brain and spinal cord protein phosphorylation after a single oral administration of tri-o-cresyl phosphate to hens. J. Neurochem. 45: 1567-1577. (Pubitemid 16252599)
69. Patton, S. E., Lapadula, D. M., and Abou-Donia, M. B. 1986. Relationship of tri-o-cresyl phosphate-induced delayed neurotoxicity to enhancement of in vitro phosphorylation of hen brain and spinal cord proteins. J. Pharmacol. Exp. Ther. 239: 597-605. (Pubitemid 17183192)
70. Pollard, K. M., Haltman, P., and Kono, D. H. 2010. Toxicology of autoimmune diseases. Chem. Res. Toxicol. 23: 455-466.
71. Rayman, R. 2002. Cabin quality: An overview. Aviation Space Environ. Med. 73: 211-215.
72. Ross, S. M. 2008. Cognitive function following exposure to contaminated air on commercial aircraft: A case series of 27 pilots seen for clinical purpose. J. Nutr. Environ. Med. 17: 111-126.
73. Rubey,W. A., Striebich, R. C., Bush, J., Centers, P. W., and Wright, R. L. 1966. Neurotoxin formation from pilot-scale incineration of synthetic ester turbine lubricants with tricresyl phosphate additives. Arch. Toxicol. 70: 508-509.
74. Schoper, l. M., Furlong, C. E., and Lockridge, O. 2010. Development of diagnostics in the search for an explanation of aerotoxic syndrome. Anal. Biochem. 404: 64-74.
75. Shiiya, N., Kunihara, T., Miyatake, T., Matsuzaki, K., and Yasuda, K. 2004. Tau Protein in the cerebrospinal fluid is a marker of brain injury after aortic surgery. Ann. Thorac. Surg. 77: 2034-2038. (Pubitemid 38686580)
76. Smith, M. I., Elvove, I., Valaer, P. J., Frazier, W. H., and Mallory G. E. 1930. Pharmacologic and chemical studies of the cause of the so-called ginger paralysis. U.S. Public Health Rep. 45: 1703-1716.
77. Spillantini, M. G., and Goedert, M. 1998. Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21: 428-433. (Pubitemid 28449072)
78. Solbu, K., Thorud, S., Hersson, M., Ovrebø, S., Ellingsen, D. G., Lundanes, E., and Molander, P. 2007. Determination of airborne trialkyl and triaryl organophosphates originating from hydraulic fluids by gas chromatographymass spectrometry. Development of methodology for combined aerosol and vapor sampling. J. Chromatogr. A 17: 275-283. (Pubitemid 47096731)
79. Suwita, W. L., and Abou-Donia, M. B. 1990. Pharmacokinetics and metabolism of a single subneurotoxic dose of tri-o-cresyl phosphate. Arch. Toxicol. 64: 237-241. (Pubitemid 20151267)
80. Suwita, E., Lapadula, D. M., and Abou-Donia, M. B. 1986a. Calcium and calmodulinenhanced in vitro phosphorylation of hen brain cold-stable microtubules and spinal cord neurofilament triplet proteins after a single dose of tri-o-cresyl phosphate. Proc. Natl. Acad. Sci. USA 76: 4350-4354.
81. Suwita, E., Lapadula, D. M., and Abou-Donia M. B. 1986b. Calcium and calmodulin stimulate in vitro phosphorylation of rooster brain tubulin and MAP-2 following a single oral dose of tri-o-cresyl phosphate. Brain Res. 374: 199-203 (Pubitemid 16078117)
82. Thrasher, J. D., Heuser, G., and Broughton, A. 2002. Immunological abnormalities in human chronically exposed to chlorpyrifos. Arch. Environ. Health 57:181-187. (Pubitemid 36014928)
83. Wendosell, F., Serrano, L., Hernandez, M. A., and Avila, J. 1986. Phosphorylation of tubulin by a calmodulin-dependent protein kinase. J. Biol. Chem. 261: 10332-10339. (Pubitemid 17221971)
84. Tagliaferro, P., Ramos, A. J., Onaivi, E. S, Evrard, S. G., Lujilde, J., and Brusco, A. 2005. Neuronal cytoskeleton and synaptic densities are altered after a chronic treatment with cannabinoid receptor agonistWIN 55,212-2. Brain Res. 1085: 163-176.
85. Van Netten, C. 1998. Air quality and health effects associated with operation of BAe 146-200 aircraft. Appl. Occup. Environ. Hyg. 13: 733-739. (Pubitemid 28449790)
86. van Netten C. 2009. Design of a small air monitor and its application in aircraft. Sci. Total Environ. 407: 1206-1210.
87. van Netten C., and Leung V. 2001. Hydraulic fluids and jet engine oil: Pyrolysis and aircraft air quality. Arch. Environ. Health 56: 181-186.
88. Wandosell, F., Serrano, L., Hernandez, M. A., and Avila, J. 1986. Phosphorylation of tubulin by a calmodulin-dependent protein kinase. J. Biol. Chem. 261: 10332-10339. (Pubitemid 17221971)
89. Weiner, M. L., and Jortner, B. S. 1999. Organophosphate-induced delayed neurotoxicity ot triarylphosphate. NeuroToxicology 20: 653-673.
90. Winder, C. 2006. Hazardous chemicals on jet aircraft: case study-Jet engine oils and aerotoxic syndrome. Curr. Topics Toxicol. 3: 65-88.
91. Winder, C., and Balouet, J. 2002. The toxicity of commercial jet oils. Environ. Res. 89: 146-164. (Pubitemid 34680884)
92. Winder, C., Fonteyn, P., and Balouet, J. 2002. Aerotoxic syndrome: A descriptive epidemiological survey of aircrew exposed to incabin airborne contaminants. J. Occup. Health Safety Aust. N. Z. 18:321-338.
93. Zurek, J., and Fedora, M. 2012. The usefulness of S100B, NSE, GFAP, NFH secretagogue and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochem. 154: 93-103.